Regiospecific synthesis of pyrido[3,4-b]- and pyrido[4,3-b]carbazole- 5,11-dione derivatives. Evaluation of their in vitro antifungal or antiprotozoological activities

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 5, 1999, Pages 643-646

  Poumaroux, Ambroise ^a   Bouaziz, Zouhair ^a   Fillion, Houda ^a   Domard, Monique ^a   Giraud, Josette ^a   Pétavy, Anne Françoise ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

2 azadiene; Antifungal activity; Antiprotozoological activity; Bromocarbazolequinone; Diels Alder; Pyridocarbazolequinone

Indexed keywords

10 ETHYL 2 METHYL 2H PYRIDO[3,4 B]CARBAZOL 3,5,11 (10H) TRIONE; 10 ETHYL 2H PYRIDO[3,4 B]CARBAZOL 3,5,11(10H) TRIONE; 10 ETHYL 3 METHOXYPYRIDO[3,4 B]CARBAZOL 5,11(10H) DIONE; 5,11 DIACETOXY 6 ETHYL 3 METHOXY 6H PYRIDO[4,3 B]CARBAZOLE; 6 ETHYL 2 METHYL 2H PYRIDO[4,3 B]CARBAZOL 3,5,11(6H) TRIONE; 6 ETHYL 2H PYRIDO[4,3 B]CARBAZOL 3,5,11(6H) TRIONE; 6 ETHYL 3 METHOXYPYRIDO[4,3 B]CARBAZOL 5,11(6H) DIONE; CARBOQUONE; PYRIDO[3,4 B]CARBAZOLE 5,11 DIONE DERIVATIVE; PYRIDO[4,3 B]CARBAZOLE 5,11 DIONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CRYPTOCOCCUS NEOFORMANS; DRUG SYNTHESIS; ISOMERISM; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PHYSICAL CHEMISTRY; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TRICHOMONAS VAGINALIS;

EID: 0033041073     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.643     Document Type: Article

References (20)

1. a) Furukawa H., Wu T.-S., Ohte T., Kuoh C.-H., Chem. Pharm. Bull., 33, 4132-4138 (1985);
2. b) Ito C., Nakagawa M., Wu T.-S., Furukawa H., Chem. Pharm. Bull., 39, 2525-2528 (1991).
3. Furukawa H., Yogo M., Ito C., Wu T.-S., Kuoh C. S., Chem. Pharm. Bull., 33, 1320-1322 (1985).
4. Wu T.-S., Huang S. C., Wu P. L., Lee K. H., Bioorg. Med Chem. Lett., 4, 2395-2397 (1994).
5. Takeya K., Itoigawa M., Furukawa H., Eur. J. Pharmacol., 169, 137-145 (1989).
6. Hammam A. S., Abdel Rahman A. E., El-Maghraby M. A., Mohamed F. K., Indian J. Chem., 21B, 348-351 (1982).
7. a) Goodwin S., Smith A. F., Horning E. C., J. Am. Chem. Soc., 81, 1903-1908 (1959);
8. b) Woodward R. B., Iacobucci G. A:, Hochstein F. A., J. Am. Chem. Soc., 81, 4434-4435 (1959).
9. a) Dalton L. K., Demerac S., Elmes B. C., Loder J. W., Swan J. M., Teitei T., Aust. J. Chem., 20, 2715-2727 (1967);
10. b) Svoboda G. H., Poore G. A., Monfort M. L., J. Pharm. Sci., 57, 1720- 1728 (1968).
11. a) Taylor D. A., Baradarani M. M., Martinez S. J., Joule J. A., J. Chem. Res., (M), 4801-4817 (1979);
12. b) Ashcroft W. R., Beal M. G., Joule J. A., J. Chem. Soc., Chem. Commun., 1981, 994-995;
13. c) Ashcroft W. R., Dalton L., Beal M. G., Humphrey G. L., Joule J. A., J. Chem. Soc., Perkin Trans. 1, 1983, 2409-2412.
14. Poumaroux A., Bouaziz Z., Domard M., Fillion H., Heterocycles, 45, 585-596 (1997).
15. Lee J., Snyder J. K., J. Org. Chem., 55, 4995-5008 (1990).
16. Stewart J. J. P., J. Comput. Chem., 10, 209-220 (1989).
17. Bayard P., Sainte F., Beaudegnies R., Ghosez L., Tetrahedron Lett., 29, 3799-3802 (1988).
18. Datry A., Carrière J., Le Pitre M., Goussin H., Silberstien C., Danis M., Méd. Mal. Infect., 25, 6-13 (1995).
19. Andrew P., Haberkorn A., Thomas H., "Antiparasitic Drugs: Mechanism of Action, Pharmacokinetics, and In Vitro and In Vivo Assays of Drug Activity," ed. by V. Lorian, Antibiotics in Laboratory Medicine, Williams and Wilkins, Baltimore, 1986, pp. 282-345.
20. Juliano C., Mattana A., Capuccinelli P., Eur. J. Drug Res. 2, Suppl. 1, 139-141 (1993).